Results 11 to 20 of about 2,744,211 (203)
Codelivery of zoledronic acid and double-stranded RNA from core-shell nanoparticles
International Journal of Nanomedicine, 2013 Li Chen,1 Yunfei Ding,2 Yongzhong Wang,3 Xingrong Liu,2 RJ Babu,1 WR Ravis,1 Weili Yan21Department of Pharmaceutical Sciences, Harrison School of Pharmacy, Auburn University, Auburn, AL, USA; 2Department of Pharmaceutical Sciences, College of Life ...
Yan W +6 more
doaj +1 more source
Dosing of zoledronic acid with its anti-tumor effects in breast cancer
Journal of Bone Oncology, 2015 Bisphosphonates have played an important role in the treatment of breast cancer, mainly in patients with bone metastasis, by reducing the risk of fracture, spinal cord compression, and hypercalcemia.
Xinmin Zhao, Xichun Hu
doaj +2 more sources
Treatment of osteoporosis with annual iv zoledronic acid: effects on hip fracture
Therapeutics and Clinical Risk Management, 2009 Roland D ChapurlatINSERM U831, Université de Lyon, Division of Rheumatology, Hôpital E Herriot, Hospices Civils de Lyon, Lyon, FranceBackground: Several treatments for postmenopausal osteoporosis have been available in the past ...
Rol, D Chapurlat
doaj +1 more source
Once-yearly zoledronic acid in the prevention of osteoporotic bone fractures in postmenopausal women
Clinical Interventions in Aging, 2008 Irene Lambrinoudaki, Sophia Vlachou, Fotini Galapi, Dimitra Papadimitriou, K Papadias2nd Department of Obstetrics and Gynecology, University of Athens, Aretaieio Hospital, GreeceAbstract: Zoledronic acid is a nitrogen-containing, third-generation ...
Irene Lambrinoudaki +4 more
doaj +1 more source
Delayed Inflammatory Reaction to Hyaluronic Acid Dermal Filler Following Zoledronic Acid Administration: A Case Report [PDF]
Clinical, Cosmetic and Investigational DermatologyNada J Alghamdi,1,* Serene R Almuhaidib,2,* Abdulmajeed S Alharbi,2,* Abdullah Ali N Aljalfan,1,* Khalid M Al-Husain1 1Department of Dermatology, King Fahd University Hospital, Al Khobar, Saudi Arabia; 2College of Medicine, Imam ...
Alghamdi NJ +4 more
doaj +1 more source
Clinical efficacy and safety of zoledronic acid in osteoporosis and Paget's disease [PDF]
, 2009 Osteoporosis and Paget’s bone disease are the most common diseases of the bone. In addition to glucocorticoid treatment, there are many other secondary causes of osteoporosis. Bisphosphonates are used to treat these bone conditions.
Doggrell, Sheila, Sheila A Doggrell
core +1 more source
Annual Zoledronic Acid for the Treatment of Osteoporosis: A Randomized Controlled Trial
Journal of Orthopedics, Traumatology and Rehabilitation, 2023 Context: Osteoporosis remains a significant public health problem in many parts of the world, including India. The efficacy of oral bisphosphonates is lower because of poor compliance.
Asif Hussain +5 more
doaj +1 more source
Jurnal Manajemen dan Pelayanan Farmasi, 2020 Zoledronic acid and ibandronic acid are listed in the Indonesian national formulary to prevent skeletal-related events (SRE) in patients diagnosed with bone metastasis in multiple myeloma (MM), with limited evidence to compare their effectiveness.
Nutrisia Aquariushinta Sayuti +3 more
doaj +1 more source
PLoS ONE, 2012 BackgroundZoledronic acid is widely used as adjuvant chemotherapy for the treatment of breast cancer. However, previous trials reported inconsistent findings regarding their clinical efficacy and safety.
Wei-Wei Huang +4 more
doaj +1 more source
Zoledronic acid: clinical utility and patient considerations in osteoporosis and low bone mass [PDF]
, 2010 Ronald C Hamdy1,21Chair, Quillen Chair of Geriatrics and Gerontology, Quillen College of Medicine, East Tennessee State University, 2Staff Physician, Mountain Home Veterans’ Administration, Tennessee, USA Abstract: The availability of a once-a ...
Ronald C Hamdy +2 more
core +1 more source